Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that…